Skip to content

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01238250
Enrollment
100000
Registered
2010-11-10
Start date
2010-10-01
Completion date
2050-10-01
Last updated
2026-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

15q11.2 BP1-BP2 Deletion, 15Q13.3 Deletion Syndrome, 15q15 Deletions, 15Q24 Deletion, 16P11.2 Deletion Syndrome, 16p11.2 Duplications, 16p11.2 Triplications, 16P12.2 Microdeletion, 16P13.11 Microdeletion Syndrome (Disorder), 16p13.3 Deletion, 17p13.3, 17Q11.2 Microduplication Syndrome (Disorder), 17Q12 Duplication Syndrome, 17Q12 Microdeletion Syndrome (Disorder), 17Q21.31 Deletion Syndrome, 17q21.3 Duplications, 1Q21.1 Deletion, 1Q21.1 Microduplication Syndrome (Disorder), 2p16.3 Deletions, 2q37.3 Deletion, 2Q37 Deletion Syndrome, 5P Deletion Syndrome, 5q35 Deletions, 5q35 Duplications, 6q16 Deletion, 7q11.23 Duplications, 9q34 Duplications, ACTB, ACTL6B, ADNP, ADSL, AFF2, AHDC1, ALDH5A1, ANK2, ANK3, ANKRD11, ARHGEF9, ARID1B, ARX, ASH1L, ATRX Gene Mutation, AUTS2 Syndrome, BCKDK, BCL11A, BRSK2, CACNA1C, CAPRIN1, CASK, CASZ1, CHAMP1, CHD2, CHD3, CHD8, CIC, CLCN4, CNOT3, CREBBP Gene Mutation, CSDE1, CSNK2A1, CSNK2B, CTBP1, CTCF, CTNNB1 Gene Mutation, CUL3, DDX3X, DEAF1, DHCR7, DLG4, DNMT3A, DSCAM, DYNC1H1, DYRK1A, EBF3, EHMT1, EIF3F, EP300 Gene Mutation, FOXP1, FOXP2, GIGYF1, GNB1, GRIN1, GRIN2A, GRIN2B, GRIN2D, HECW2, HIVEP2-Related Intellectual Disability, HNRNPC, HNRNPD, HNRNPH2, HNRNPK, HNRNPR, HNRNPU, HNRNPUL2, IQSEC2-Related Syndromic Intellectual Disability, IRF2BPL, ITSN1, KANSL1, KATNAL2, KCNB1, KDM3B, KDM5B, KDM6B, KMT2A, KMT2C Gene Mutation, KMT2E, KMT5B, MAOA, MAOB, MBD5, MBOAT7, MED13, MED13L, MEF2C, MEIS2, MYT1L, NAA15, NBEA, NCKAP1, NEXMIF, NIPBL, NLGN2, NLGN3, NLGN4X, NR3C2, NR4A2, NRXN1, NRXN2, NSD1 Gene Mutation, PACS1, PACS2, PHF21A, PHF3, PHIP, PPM1D, PPP2R1A, PPP2R5D-Related Intellectual Disability, PPP3CA, PSMD12, PTCHD1, RALGAPB, RELN, RERE, REST, RFX3, RIMS1, RNU4-2, RORB, SCN1A, SCN1B, SCN2A Encephalopathy, SETBP1 Gene Mutation, SETD2 Gene Mutation, SETD5, SHANK2, SIN3A, SLC6A1, SLC9A6, SMARCA4 Gene Mutation, SMARCC2, SNAP25, SON, SOX5, SPAST, SRCAP, STXBP1 Encephalopathy With Epilepsy, SYNCRIP, SYNGAP1-Related Intellectual Disability, TANC2, TAOK1, TBR1, TCF20, TCF7L2 Gene Mutation, TLK2, TRIO, TRIP12, UPF3B, USP9X, VPS13B, WAC, WDFY3, Xp11.22 Duplication, Xq28 Duplication, YY1, ZBTB20, ZNF292, ZNF462

Keywords

16p11.2, 16p11.2 del, 16p11.2 deletion, 16p11.2 dup, 16p11.2 duplication, chromosome 16, chromosome 16p, chromosome 16p11, chromosome 16p11.2, 1q21.1, 1q21.1 del, 1q21.1 deletion, 1q21.1 dup, 1q21.1 duplication, chromosome 1, chromosome 1q, chromosome 1q21, chromosome 1q21.1, genetic mutation, genetic variant, gene variant, ADNP, ANKRD11, ARID1B, ASXL3, ACTL6B, AHDC1, BAF190, ANK2, ASH1L, BCL11A, CHD2, CHD8, CTNNB1, CUL3, DYRK1A, FOXP1, GRIN2B, KDM6B, KMT2E, MBD5, MED13L, REST, SCN2A, SMARCC2, SYNGAP1, HIVEP2, HNRNPH2, PPP2R5D, CHAMP1, CSNK2A1, CTBP1, DDX3X, DNMT3A, DSCAM, GRIN2A, KATNAL2, KDM5B, KMT2C, KMT5B, SUV420H1, PACS1, PTCHD1, SETBP1, SETD5, SMARCA4, STXBP1, TBR1, ARHGEF9, HNRNPU, PPP2B, PPP2R1A, SLC6A1, PACS2, MAOA, MAOB, HNRNPC, HNRNPD, HNRNPK, HNRNPR, HNRNPUL2, 5P Deletion Syndrome, TCF7L2, HECW2, PPM1D, RNU4-2, SNAP25, FOXP2, ITSN1

Brief summary

Simons Searchlight is an observational, online, international research program for families with rare genetic variants that cause neurodevelopmental disorders and may be associated with autism. Simons Searchlight collects medical, behavioral, learning, and developmental information from people who have these rare genetic changes. The goal of this study is to improve the clinical care and treatment for these people. Simons Searchlight partners with families to collect data and distribute it to qualified researchers.

Detailed description

Simons Searchlight has expanded over the last several years to include additional gene changes and participation through remote formats, either online or by phone. This allows English and Spanish-speaking families from across the world to participate at times that are convenient to their schedule. Participants can donate blood, saliva, or both. These samples are then linked to medical, behavioral, learning, and developmental data in order to understand the effects of specific gene changes. Information provided by participants will be stripped of any personal identifying information and made available to qualified scientists around the world. The Simons Foundation, a New York-based private foundation, is committed to finding science-based solutions and working towards the development of targeted treatments to improve the lives of people who have genetic and developmental differences.

Interventions

None listed

Sponsors

Simons Searchlight
Lead SponsorOTHER
Geisinger Clinic
CollaboratorOTHER
Boston Children's Hospital
CollaboratorOTHER
Simons Foundation
CollaboratorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subjects of any age with a genetic condition on our eligible list along with their biological family members. Current list can be found at: https://www.simonssearchlight.org/research/what-we-study/ * Must be fluent in English or a supported language. Current supported languages are Spanish, French, and Dutch, with more to come. * Able to register and participate through our online platform, which can be accessed through any device able to connect to the internet. * Able and willing to provide consent.

Exclusion criteria

-Some genetic changes that we study have regions or variants that are not eligible for our research. This is determined during our laboratory review that is completed by trained and certified genetic counselors. These specific ineligible regions or variants can change frequently.

Design outcomes

Primary

MeasureTime frameDescription
Baseline comprehensive collection of medical, behavioral, learning, and developmental information of people who have documented gene changes that are associated with features of autism and other neurodevelopmental disorders.Baseline data is collected over the course of one month, on average.Families with people who have specific documented gene changes that are associated with features of autism and other neurodevelopmental disorders will report detailed medical and family history information by phone. Online research surveys will be used to collect information about behavioral and learning characteristics, with the goal of improving clinical care and treatment for these people.

Secondary

MeasureTime frameDescription
Longitudinal, or long-term, comprehensive collection of medical, behavioral, learning, and developmental information from people who have documented gene changes that are associated with features of autism and other neurodevelopmental disorders.Repeat data collection will occur on a regular basis and will be obtained over the course of one month, on averageTo monitor and document the development of people who have gene changes that are related to autism and other neurodevelopmental disorders, online research surveys and updates to the family and medical history will be collected on an annual basis.

Countries

United States

Contacts

CONTACTSimons Searchlight Study Coordinator
coordinator@SimonsSearchlight.org855-329-5638
PRINCIPAL_INVESTIGATORCora Taylor, PhD

Geisinger Clinic

PRINCIPAL_INVESTIGATORWendy Chung, MD PhD

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 24, 2026